Cancer breakthrough: New method destroys 99% of cells

Scientists at Rice University have unlocked a groundbreaking method using aminocyanine molecules, commonly used in medical imaging, to target and destroy cancer cells. This method demonstrates an extraordinary success rate in laboratory settings.

Publication: 02.01.2024 - 11:52
Cancer breakthrough: New method destroys 99% of cells
Abone Ol google-news

These specialized molecules, when activated by near-infrared light, vibrate collectively to form a "plasmon," leading to the rupture of cancer cells' membranes. This process, described as “molecular jackhammers,” offers a highly effective treatment, with potential implications for a wide range of cancers.

Impressive Laboratory Results

In laboratory tests, the treatment achieved a staggering 99 percent success rate against human melanoma cells. In addition, animal studies have shown significant results, with half of the melanoma-afflicted mice becoming cancer-free post-treatment.

Expert Insights

Ciceron Ayala-Orozco from Rice University explains the uniqueness of this approach and its potential to change cancer treatment. He emphasizes the simplicity and biocompatibility of these molecules, now repurposed to activate as plasmons and treat cancer at a molecular level.

Future of Cancer Treatment

This method's ability to use near-infrared light could revolutionize cancer treatment, potentially allowing for non-invasive procedures even in difficult-to-reach areas like bones and internal organs. This research adds to a series of recent breakthroughs in the field of oncology, paving the way for more effective and less invasive cancer treatments.

Ongoing Progress in Oncology

The study is part of a broader advancement in cancer research, including last year's introduction of a cancer-killing virus and the development of self-destructive methods for cancer cells. Moderna's recent vaccine, reducing the risk of certain skin cancers, further illustrates the rapid progress in this field. These developments offer new hope and avenues in the fight against cancer.

Most Read News